Journal of Pharmaceutical and Biomedical Analysis 1993-10-01

Degradation profile and reversed-phase LC method development of the antiinflammatory drug, Ro 24-5913.

N D Aggarwal, D Goldman, A W Malick, K Sethachutkul

Index: J. Pharm. Biomed. Anal. 11(10) , 1037-43, (1993)

Full Text: HTML

Related Compounds

Participation of leukotriene C(4) in the regulation of suicidal erythrocyte death.

2009-09-01

[J. Physiol. Pharmacol. 60(3) , 135-43, (2009)]

Prolonged protection against exercise-induced bronchoconstriction by the leukotriene D4-receptor antagonist cinalukast.

1997-02-01

[J. Allergy Clin. Immunol. 99(2) , 210-5, (1997)]

Heterogeneity of binding sites for ICI 198,615 in human lung parenchyma.

1992-10-06

[Biochem. Pharmacol. 44(7) , 1411-5, (1992)]

Pharmacologic actions of Ro 24-5913, a novel antagonist of leukotriene D4.

1991-11-01

[J. Pharmacol. Exp. Ther. 259(2) , 751-8, (1991)]

Temperature sensitivity of suicidal erythrocyte death.

2010-06-01

[Eur. J. Clin. Invest. 40(6) , 534-40, (2010)]